High Vista Strategies LLC Guardant Health, Inc. Transaction History
High Vista Strategies LLC
- $241 Million
- Q2 2025
A detailed history of High Vista Strategies LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 28,265 shares of GH stock, worth $2.61 Million. This represents 0.61% of its overall portfolio holdings.
Number of Shares
28,265
Previous 51,718
45.35%
Holding current value
$2.61 Million
Previous $2.2 Million
33.27%
% of portfolio
0.61%
Previous 0.96%
Shares
3 transactions
Others Institutions Holding GH
# of Institutions
424Shares Held
126MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$1.12 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$1.04 Billion0.01% of portfolio
-
Baillie Gifford & CO5.13MShares$474 Million0.25% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$460 Million0.05% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$393 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $9.45B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...